These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38823470)

  • 1. Discovery of a CCR2-targeting pepducin therapy for chronic pain.
    Midavaine É; Brouillette RL; Théberge E; Mona CE; Kashem SW; Côté J; Zeugin V; Besserer-Offroy É; Longpré JM; Marsault É; Sarret P
    Pharmacol Res; 2024 Jul; 205():107242. PubMed ID: 38823470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic insights into the role of the chemokine CCL2/CCR2 axis in dorsal root ganglia to peripheral inflammation and pain hypersensitivity.
    Dansereau MA; Midavaine É; Bégin-Lavallée V; Belkouch M; Beaudet N; Longpré JM; Mélik-Parsadaniantz S; Sarret P
    J Neuroinflammation; 2021 Mar; 18(1):79. PubMed ID: 33757529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of chemokine CCL2/CCR2 signaling in the dorsal root ganglion and spinal cord to the maintenance of neuropathic pain in a rat model of lumbar disc herniation.
    Zhu X; Cao S; Zhu MD; Liu JQ; Chen JJ; Gao YJ
    J Pain; 2014 May; 15(5):516-26. PubMed ID: 24462503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.
    Kwiatkowski K; Piotrowska A; Rojewska E; Makuch W; Mika J
    J Neuroimmune Pharmacol; 2017 Sep; 12(3):402-419. PubMed ID: 28337574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses.
    Kwiatkowski K; Ciapała K; Rojewska E; Makuch W; Mika J
    Int Immunopharmacol; 2020 Jul; 84():106540. PubMed ID: 32402949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development.
    Bégin-Lavallée V; Midavaine É; Dansereau MA; Tétreault P; Longpré JM; Jacobi AM; Rose SD; Behlke MA; Beaudet N; Sarret P
    Mol Pain; 2016; 12():. PubMed ID: 27306408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-penetrating pepducins targeting the neurotensin receptor type 1 relieve pain.
    Brouillette RL; Besserer-Offroy É; Mona CE; Chartier M; Lavenus S; Sousbie M; Belleville K; Longpré JM; Marsault É; Grandbois M; Sarret P
    Pharmacol Res; 2020 May; 155():104750. PubMed ID: 32151680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell.
    Wu XB; Jing PB; Zhang ZJ; Cao DL; Gao MH; Jiang BC; Gao YJ
    Neuropsychopharmacology; 2018 Oct; 43(11):2320-2330. PubMed ID: 29993042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCL2/CCR2 signaling elicits itch- and pain-like behavior in a murine model of allergic contact dermatitis.
    Jiang H; Cui H; Wang T; Shimada SG; Sun R; Tan Z; Ma C; LaMotte RH
    Brain Behav Immun; 2019 Aug; 80():464-473. PubMed ID: 30981714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2.
    Abbadie C; Lindia JA; Cumiskey AM; Peterson LB; Mudgett JS; Bayne EK; DeMartino JA; MacIntyre DE; Forrest MJ
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7947-52. PubMed ID: 12808141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule angiotensin II type 2 receptor (AT₂R) antagonist produces analgesia in a rat model of neuropathic pain by inhibition of p38 mitogen-activated protein kinase (MAPK) and p44/p42 MAPK activation in the dorsal root ganglia.
    Smith MT; Woodruff TM; Wyse BD; Muralidharan A; Walther T
    Pain Med; 2013 Oct; 14(10):1557-68. PubMed ID: 23742186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain.
    Jung H; Bhangoo S; Banisadr G; Freitag C; Ren D; White FA; Miller RJ
    J Neurosci; 2009 Jun; 29(25):8051-62. PubMed ID: 19553445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CC Chemokine Receptor Type 3 Diminishes Pain and Enhances Opioid Analgesic Potency in a Model of Neuropathic Pain.
    Pawlik K; Ciechanowska A; Ciapała K; Rojewska E; Makuch W; Mika J
    Front Immunol; 2021; 12():781310. PubMed ID: 34795678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain.
    Serrano A; Paré M; McIntosh F; Elmes SJ; Martino G; Jomphe C; Lessard E; Lembo PM; Vaillancourt F; Perkins MN; Cao CQ
    Mol Pain; 2010 Dec; 6():90. PubMed ID: 21143971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levo-Corydalmine Alleviates Neuropathic Cancer Pain Induced by Tumor Compression via the CCL2/CCR2 Pathway.
    Hu Y; Kodithuwakku ND; Zhou L; Li C; Han D; Fang W; Liu J; Li Y
    Molecules; 2017 Jun; 22(6):. PubMed ID: 28587280
    [No Abstract]   [Full Text] [Related]  

  • 17. CCL2 facilitates spinal synaptic transmission and pain via interaction with presynaptic CCR2 in spinal nociceptor terminals.
    Ma SB; Xian H; Wu WB; Ma SY; Liu YK; Liang YT; Guo H; Kang JJ; Liu YY; Zhang H; Wu SX; Luo C; Xie RG
    Mol Brain; 2020 Nov; 13(1):161. PubMed ID: 33228784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia.
    Kwiatkowski K; Popiolek-Barczyk K; Piotrowska A; Rojewska E; Ciapała K; Makuch W; Mika J
    Cytokine; 2019 Jul; 119():202-213. PubMed ID: 31003094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spinal Wnt5a Plays a Key Role in Spinal Dendritic Spine Remodeling in Neuropathic and Inflammatory Pain Models and in the Proalgesic Effects of Peripheral Wnt3a.
    Simonetti M; Kuner R
    J Neurosci; 2020 Aug; 40(35):6664-6677. PubMed ID: 32616667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms.
    Wen J; Jones M; Tanaka M; Selvaraj P; Symes AJ; Cox B; Zhang Y
    J Neuroinflammation; 2018 Jan; 15(1):9. PubMed ID: 29310667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.